UFP Technologies, Inc. (UFPT) स्टॉक विश्लेषण

कंपनी का अवलोकन

UFP Technologies, Inc. operates as a specialized manufacturer within the healthcare sector, specifically focusing on the medical devices industry. The company designs, manufactures, and supplies engineered custom products, including protective drapes for robotic surgery, sterile packaging solutions, advanced wound care items, and patient handling equipment used across the United States. This operational scope places the firm in a critical segment of the healthcare supply chain where reliability and sterility are paramount for patient safety and surgical outcomes. In terms of scale, UFP Technologies holds a market capitalization of $1.55B and reported annual revenue of $602.80M, supported by a workforce of 4,846 employees. The valuation metric of $1.55B suggests that the market assigns a significant premium to the company's future cash flow potential relative to its tangible assets, while the revenue figure of $602.80M indicates a substantial operational footprint capable of influencing pricing dynamics in the sterile packaging and device markets. The employee count of 4,846 reflects a mature organization with extensive manufacturing and distribution capabilities necessary to serve a broad range of medical institutions.

वित्तीय स्वास्थ्य

The company reported a trailing twelve-month revenue of $602.80M, which generated a net income of $68.31M and an EBITDA of $112.18M. The substantial gap between the $602.80M revenue and the $68.31M net income reveals a cost structure where operating expenses, including cost of goods sold, depreciation, and administrative costs, consume approximately 88.7% of total sales before interest and taxes. Free cash flow stands at $65.67M, which demonstrates a strong ability to generate liquidity from operations after capital expenditures, providing the financial flexibility to fund research, development, or debt reduction without relying solely on external financing. Profitability is further detailed by three distinct margin metrics: a gross margin of 28.3%, an operating margin of 14.1%, and a profit margin of 11.3%. The gross margin of 28.3% indicates that production costs are significant relative to sales, while the operating margin of 14.1% and profit margin of 11.3% show that after covering all operational and tax obligations, the company retains a healthy portion of revenue as earnings. Regarding capital structure, total cash on hand is $20.30M, which is significantly lower than the total debt of $154.48M, resulting in a debt-to-equity ratio of 36.45. This leverage position indicates that the balance sheet is moderately leveraged, relying on equity to support a level of debt that exceeds available cash reserves, requiring consistent cash flow generation to meet obligations. Liquidity is robust, evidenced by a current ratio of 2.69, which signifies that the company holds more than double the current assets required to cover its short-term liabilities. Return on equity is 17.8% and return on assets is 9.1%, metrics that reveal management is effectively deploying shareholder capital and utilizing the company's asset base to generate substantial returns.

मूल्यांकन आकलन

Valuation multiples for UFP Technologies include a trailing P/E ratio of 22.89 and a forward P/E of 17.51. The notable difference between the trailing P/E of 22.89 and the forward P/E of 17.51 implies that the market expects earnings to grow significantly in the future, compressing the valuation multiple as anticipated profitability increases. The price-to-book ratio stands at 3.65, indicating that the market values the company at a significant premium over its tangible book value, reflecting intangible assets like brand reputation, patents, and proprietary technology. Alternative valuation metrics such as the price-to-sales ratio of 2.57 and an EV/EBITDA of 14.98 provide additional context, suggesting the stock is priced moderately relative to its sales volume and enterprise value adjusted for earnings power. Price volatility is contextualized by a 52-week high of $274.93 and a 52-week low of $182.87, placing the current trading range within a band defined by these extremes. The beta value of 1.17 indicates that the stock exhibits higher volatility than the broader market, meaning price movements are amplified relative to general market fluctuations.

Growth & Income

The company's growth trajectory is defined by a revenue growth rate of 3.4% year-over-year and an earnings growth rate of 6.8% year-over-year. Earnings are growing faster than revenue, as the 6.8% earnings growth exceeds the 3.4% revenue growth, which implies improving operational efficiency, cost control, or a favorable shift in product mix that enhances profitability per unit sold. As a non-dividend payer, the company has a dividend yield of N/A and a payout ratio of 0.0%, indicating that the firm reinvests all of its net income back into the business for expansion, R&D, or debt repayment rather than distributing cash to shareholders. This retention strategy prioritizes long-term capital appreciation and operational scaling over immediate income generation for investors. Overall, the growth and income profile is characterized by moderate revenue expansion, accelerating earnings growth driven by margin improvements, and a capital allocation strategy focused entirely on internal reinvestment rather than dividend distribution.